Navigation Links
Response Genetics Announces Presentation/Webcast at BIOCOM Investor Conference
Date:10/31/2007

LOS ANGELES, Oct. 31 /PRNewswire-FirstCall/ -- Response Genetics, Inc. (Nasdaq: RGDX) today announced its President and CEO, Kathleen Danenberg, will provide a business overview, including an update on its ERCC-1 molecular diagnostic gene expression test for cisplatin-based chemotherapy resistance, at the BIOCOM Investor Conference at the San Diego Marriot Del Mar in San Diego October 31 to November 2. Ms. Danenberg will present at 5:30 p.m. PT Thursday, Nov. 1.

The presentation will be made available by webcast and can be accessed on the Media page of Response Genetics' website at http://www.responsegenetics.com.

About Response Genetics, Inc.

Response Genetics, Inc. ("RGI") (Nasdaq: RGDX) is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies. RGI's technologies enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin embedded specimens. RGI currently generates revenue primarily from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. The company was founded in 1999 and its principal headquarters are located in Los Angeles, California. For more information, please visit http://www.responsegenetics.com.


'/>"/>

SOURCE Response Genetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Stress response increases suicide risk
2. Gene variation simulates cholesterol response to oestrogen
3. Alcohol injures stress hormone response
4. Self control makes stress response easy
5. Perceived stress decreases vaccine response
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Harmful chemicals change the genetic response to hormone estrogen
8. Increasing Insulin Response In Type 2 Diabetics With New Protein Mixture
9. Sexes differ in response to burnout on the job and depression
10. Reflecting On Personal Values Can Lower Stress Responses
11. Chromosome Ends Trigger DNA Damage Response For Telomere Protection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...RANKLIN LAKES, N.J., Nov. 21 /PRNewswire-FirstCall...e for medical intervention in treating 88 percent ...percent of Americans treated for a chronic conditi... spending and 75 percent of all medical costs. A ...e years by Medco Health Solutions, Inc. (NYSE: M...
(Date:11/21/2008)...xperiments in mice find running increases producti... 21 (HealthDay News) -- In experiments in mice, ex...ction of brain stem cells usually seen with aging,...e restoration of the brain,s ability to stave off ...estore a neurochemical that is essential for the p...
(Date:11/21/2008)...EW YORK, Nov. 21 /PRNewswire/ -- For the second... years , McCann Healthcare Worldwide,s agency net...y network at the 22nd annual international RX Club...e agency offices won a total of 59 RX Club Awards ...e winning McCann Healthcare Worldwide agencies inc...
(Date:11/21/2008)...OSTON, Nov. 21 Innerscope Research...rm specializing in Emotional Response Measurement,...ves who will strengthen the,company,s research an...itiatives. , The three appointments, who de...Geoffrey Gill as Chief Financial Officer and Vice ...
Breaking Medicine News(10 mins):Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Exercise Keeps the Brain Young 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2
... a novel compound, CDDO-Im, shown to possess stron...imal models could soon revolutionize the treatment...n found to increase the intrinsic resistance to ca...g the function of enzymes that remove toxins from ...
...ier research institution has warned about the poss...ect to the genetic constitution of the much-dreade...hat this mutation could enable human-human bird fl...l affinity for human receptors. The company has a...
... is the world's most common liver infection. It sp...uals than the AIDS virus. It causes liver cirrhos...show that about two billion people (30 %) of the w...ected with the hepatitis B virus. Out of which 35...
...commended not to undergo frequent ultrasound scann...ove dangerous for the developing fetus, according ...Ultrasound images can show facial features, hair a...'s sex, reported health portal HealthCentral. Al...
Other Medicine News:Health News:New Compound Offers Hope In Liver Cancer Treatment 2Health News:Genetic Change In The H5N1 Virus Likely: Recombinomics Inc. 2
(Date:11/19/2008)...SAND OAKS, Calif., Nov. 19 /PRNewswire-FirstCall/ ...keda Oncology Company, a subsidiary of,Takeda Pha...ounced that,enrollment in the Phase 3 MONET1 tria...ith paclitaxel and carboplatin for the first-line ...(NSCLC) has been temporarily suspended,following ...
(Date:11/19/2008)...Jude scientists report basic findings on critical ...how to better treat an array of disorders , ,... -- Scientists at St. Jude Children,s Research Ho... one of the body,s enzyme workhorses called calpai...ers, calpains function in many cellular processes,...
(Date:11/19/2008)...RK, Del., Nov. 19 Isogen, a contra... sterile filling, today announced the first,phase...en was founded to,specifically address the proces...ated with the $2 billion highly-niched, low-volume...ing market segment. , Companies can invest ...
(Date:11/18/2008)...ON, November 19 NeuroDis...ervice provider and drug development Company,and...ex: 4565), a leading,international biopharmaceuti...s presenting further pivotal pre-clinical efficacy...g is a potential therapy for neuropathic pain and ...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Select Comfort Helps Families Sleep Better in Los Angeles 13410 1Select Comfort Helps Families Sleep Better in Los Angeles 13410 2Select Comfort Helps Families Sleep Better in Los Angeles 13410 3Cochlear implant recipients experience improvement in quality of life 13407 1A combination therapy of 3 vasodilators may treat portopulmonary hypertension 13404 1A combination therapy of 3 vasodilators may treat portopulmonary hypertension 13404 2Health Secretarys Statewide Tour to Discuss Health Insurance for All Pennsylvanians Makes Stop in Cambria County 13401 1Health Secretarys Statewide Tour to Discuss Health Insurance for All Pennsylvanians Makes Stop in Cambria County 13401 2
...NEW HAVEN, Conn., April 13, 2007 /PRNewswire-First...y that data on its lead,anticancer agent Cloretazi...the 100th Annual Meeting of the American Associati...All three posters will,be available on Vion,s webs...m.com/">www.vionpharm.com on the day of,presentat...
...ovel System May Provide Cancer Patients With Impro...alif., April 16, 2007 /PRNewswire/ -- Insert,Thera...whead,Research Corporation announced today its nov...atured in a poster presentation at,the 2007 Americ...eeting. In particular, this poster includes new re...
Other Medicine Technology:Vion Presents Data on Cloretazine (VNP40101M) at the 100th Annual,Meeting of the American Association of Cancer Research (AACR) 2Vion Presents Data on Cloretazine (VNP40101M) at the 100th Annual,Meeting of the American Association of Cancer Research (AACR) 3Vion Presents Data on Cloretazine (VNP40101M) at the 100th Annual,Meeting of the American Association of Cancer Research (AACR) 4Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4
...e SR™ Hand Implant System utilizes the same ...cements. The SR™ Hand Implant System provid...stheses including minimal bone resection, surface ...us articular surfaces, retention and/or reposition...
For use in implant resection arthroplasty of the trapeziometacarpal joint in cases of rheumatoid, degenerative or post-traumatic arthritis.
The efficient choice for small joint replacement technology -- the Ascension Silicone MCP features a similar design to our PyroCarbon MCP and utilizes the same instrumentation for intra-operative fle
...e SR™ Hand Implant System utilizes the same ...cements. The SR™ Hand Implant System provid...stheses including minimal bone resection, surface ...us articular surfaces, retention and/or reposition...
Medicine Products: